Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Enrolling By Invitation NCT07660640

Long-Term Follow Up of VOY-101 Non-nAMD Extension Study

Conditions: Age-Related Macular Degeneration (AMD), Non-Neovascular Age-Related Macular Degeneration

Sex: All

Ages: 50 Years – N/A

Healthy volunteers: No

Enrollment: 88

Sponsor: Perceive Biotherapeutics, Inc.

Location: Ophthalmic Consultants of Boston Boston Massachusetts

Summary

Long-Term Follow Up Extension for participants previously enrolled in a VOY-101 study for Advanced Non-Neovascular Age-Related Macular Degeneration

Eligibility Criteria

Inclusion Criteria: 1. Have received an injection of VOY-101 and exited either the PBI-AMD-001 or PBI-AMD-002 Phase 1/2a study of VOY-101. 2. Are willing and able to understand and provide informed consent. Exclusion Criteria: There are no exclusion criteria for this study

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07660640). StuddyBuddy aggregates publicly available trial information.